Agile Therapeutics Inc (AGRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access AGRX quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Agile Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent2.56
Marketable Securities, Current SH0.00
Cash & Short-term Investments2.00
Accounts receivable3.39
Inventories2.74
Prepaid Expense And Other Assets Current0.84
Total Current Assets9.53
Equipment/Property/Plant Net0.08
Other Assets, Noncurrent0.65
Operating Lease Right Of Use Asset0.41
Total Assets10.26
Liabilities
Accounts Payable, Current AC9.57
Accrued Liabilities, Current AC9.13
Long-term Debt, Current Maturities LO1.52
Other Liabilities, Current0.56
Total Current Liabilities20.78
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE5.70
Other liabilities, Noncurrent0.10
Operating Lease Liability Current0.19
Operating Lease Liability Noncurrent0.10
Total Liabilities26.57
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock406.85
Retained Earnings / Accumulated Deficit-423.17
Other Equity0.00
Common Stockholder's Equity-16.32
Total Stockholder's Equity-16.32
Liabilities & Stockholder's Equity10.26
4 historic quarters locked

Sign in to unlock the full Agile Therapeutics Inc balance sheet history.

About Agile Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-24-004262

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License